Fundz

Turnstone Biologics Corp. reported raising $42.1 Million in an initial SEC Form D filing, from an offering of $42.1 Million

PRIVATEJan 18, 2019

Amount Raised

$42.1 Million

$42.1 Million sold, per SEC Form D (first sale Jan 18, 2019)

Round Type

Venture

San DiegoBiotechnologyHealth CareTherapeutics

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Turnstone Biologics Corp that raised within 45 days of this round, from Fundz verified event records.

  • GENOCEA BIOSCIENCES, INC. raised $12M on February 27, 2019.
  • Neurogene raised $38M on February 25, 2019.
  • Aldeyra Therapeutics raised $10M on February 11, 2019.
  • Immunome Inc. raised an undisclosed amount on February 1, 2019.
  • Alcresta Therapeutics raised $5M on January 23, 2019.
  • Summit Therapeutics raised $25M on January 18, 2019.

Who to call at Turnstone Biologics Corp, and when

A new round usually means Turnstone Biologics Corp is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Turnstone Biologics Corp raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Turnstone Biologics Corp, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Turnstone Biologics Corp. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Turnstone Biologics Corp

Location

920 BROADWAY

San Diego, California, United States

About

Turnstone Biologics is a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (Selected TIL) therapy.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Turnstone Biologics Corp raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Turnstone Biologics Corp's next move

See what Strategic adds

Turnstone Biologics Corp raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.